enfortumab
CHEBI:CHEBI_149601
Definition
An alpha,omega-dicarboxylic acid that is pentadecanedioic acid which is substituted by methyl groups groups at positions 2 and 14, and by a hydroxy group at position 8. It is a drug used for the treatment of high LDL cholesterol, which is sometimes referred to as 'bad cholesterol'.
Chemical Information
- Molecular Formula
- C19H36O5
- Molecular Mass
- 344.492
- Charge
- 0
- SMILES
- C(C(CCCCCC(CCCCCC(C(O)=O)(C)C)O)(C)C)(O)=O
- InChI
- InChI=1S/C19H36O5/c1-18(2,16(21)22)13-9-5-7-11-15(20)12-8-6-10-14-19(3,4)17(23)24/h15,20H,5-14H2,1-4H3,(H,21,22)(H,23,24)
- InChIKey
- HYHMLYSLQUKXKP-UHFFFAOYSA-N
Alternative Names
- 8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid
- acide bempedoique
- acido bempedoico
- acidum bempedoicum
- bempedoic acid
- ESP 55016
- ESP-55016
- ETC 1002
- ETC-1002
- ETC1002
- Nexletol
Drug Classification
-
processed material
-
alpha,omega-dicarboxylic acidView Class →
CHEBI:28383
-
t111551
-
t111716
-
t111959
Important Medical Information
⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.
- Always consult with a healthcare professional before starting, stopping, or modifying any medication.
- Side effects may vary and this list may not be comprehensive.
- Drug interactions may occur with other medications.
Additional Identifiers
- DRON_00010000
- 2282403
- oboInOwl#hasDbXref
- Wikipedia:Bempedoic_acid
- core#notation
- CHEBI:149601
Additional References
🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.
Additional Attributes
- oboInOwl#hasOBONamespace
- chebi_ontology
- DRON_00010000
- 2282403
- generic_name
- Bempedoic Acid
- oboInOwl#hasDbXref
- Wikipedia:Bempedoic_acid
- oboInOwl#id
- CHEBI:149601
- brand_name
- Nexletol
- brand_name_base
- Nexletol
- product_type
- BULK INGREDIENT
- marketing_category
- BULK INGREDIENT
- listing_expiration_date
- 20241231
- dosage_form
- POWDER
- marketing_start_date
- 20221124
- labeler_name
- APICHEM Laboratories Private Limited
- product_ndc
- 24584-1120
- application_number
- NDA211616
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/chebi#3_STAR
- RO_0000087
- http://purl.obolibrary.org/obo/CHEBI_149598
- core#notation
- CHEBI:149601
- route
- ORAL
- active_ingredient_strength
- 50 kg/50kg
- package_marketing_start_date
- 24-NOV-22
- active_ingredient_name
- BEMPEDOIC ACID
- spl_id
- a6f70be4-d45e-48da-88e0-e445abff66ce
- package_ndc
- 24584-1120-1
- package_description
- 34328 TABLET, FILM COATED in 1 CONTAINER (24584-1120-1)
- pharm_class
- Adenosine Triphosphate-Citrate Lyase Inhibitors [MoA]
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- has_treatment
- http://purl.obolibrary.org/obo/DOID_6571
- owl#annotatedSource
- t112583
- owl#someValuesFrom
- t3535424